摘要
目的该实验主要探讨糖皮质激素在儿科呼吸系统疾病中的应用现状与合理性分析。方法先根据随机数字法随机选取该院2015年2月—2017年3月期间所收治400例患儿的病例资料进行回顾性分析,分析所有患儿糖皮质激素的使用情况。结果 400例患儿中,使用糖皮质激素的呼吸系统疾病患儿共有180例,占据45.00%;其中以0~3岁患儿使用的糖皮质激素的例数最多;在180例使用糖皮质激素的呼吸系统疾病患儿中,使用合理的共有128例,占据71.11%;不合理的共有52例,占据28.89%;所有使用糖皮质激素的呼吸系统患儿主要包含了:支气管哮喘、急性喘息性支气管炎、急性喉炎、支气管肺炎、新生儿肺炎、间质性肺炎、大叶性肺炎。结论该院在现阶段糖皮质激素的使用中仍旧存在着一些问题,在临床应用中需要遵守糖皮质激素的应用原则,提高药物使用的合理性。
Objective This study mainly investigated the application status and rationality of glucocorticoids in pediatric respiratory diseases. Methods According to the random number method, the data of 400 cases of children admitted to the hospital from February 2015 to March 2017 were random selected for retrospective analysis, and the use of glucocorticoids in all children was analyzed. Results Among the 400 cases, there were 180 cases of respiratory diseases using glucocorticoids, which accounted for 45.00%; Among them, the number of cases of glucocorticoids used in children aged 0-3 years was the highest; glucocorticoids were used in 180 cases. Among children with respiratory diseases, a reasonable total of 128 cases accounted for 71.11%; an unreasonable total of 52 cases, which accounted for 28.89%; all respiratory patients using glucocorticoids mainly include： bronchial asthma, acute asthmatic Bronchitis, acute laryngitis, bronchial pneumonia, neonatal pneumonia, interstitial pneumonia, and lobar pneumonia. Conclusion There are still some problems in the use of glucocorticoids in our hospital. In the clinical application, the principles of application of glucocorticoids should be followed to improve the rationality of drug use.
作者
吕小翠
LYU Xiao-cui(Department of Pharmacy,Xinyi Traditional Chinese Medicine Hospital,Xinyi,Jiangsu Province,221400 China)
出处
《中外医疗》
2018年第20期4-6,共3页
China & Foreign Medical Treatment
关键词
糖皮质激素
儿科疾病
应用现状
合理性
Glueoeortieoids
Pediatric diseases
Status of application
Rationality
